重症虚血肢(Critical Limb Ischemia):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Critical Limb Ischemia Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2430CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月28日
◆ページ数:81
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における重症虚血肢(Critical Limb Ischemia) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 重症虚血肢(Critical Limb Ischemia)
  - 当レポートの概要
・重症虚血肢(Critical Limb Ischemia):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Critical Limb Ischemia Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2014″ provides data on the Critical Limb Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Critical Limb Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Critical Limb Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Critical Limb Ischemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Critical Limb Ischemia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Critical Limb Ischemia Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Critical Limb Ischemia 33
Nov 18, 2014: Juventas Therapeutics Presents Phase II Data at AHA Scientific Sessions That Shows JVS-100 is Safe, Potentially Effective in Patients with Critical Limb Ischemia 33
Oct 05, 2014: AnGes Starts Global Phase III Clinical Trials of Collategene for Critical Limb Ischemia 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AnGes MG, Inc. 35
Clinical Trial Overview of AnGes MG, Inc. 35
ViroMed Co., Ltd. 36
Clinical Trial Overview of ViroMed Co., Ltd. 36
United Therapeutics Corporation 37
Clinical Trial Overview of United Therapeutics Corporation 37
Sanofi 38
Clinical Trial Overview of Sanofi 38
Pluristem Therapeutics Inc. 39
Clinical Trial Overview of Pluristem Therapeutics Inc. 39
TheraVitae Inc. 40
Clinical Trial Overview of TheraVitae Inc. 40
ReNeuron Group plc 41
Clinical Trial Overview of ReNeuron Group plc 41
Intrexon Corporation 42
Clinical Trial Overview of Intrexon Corporation 42
C. H. Boehringer Sohn AG & Co. KG 43
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 43
Aastrom Biosciences, Inc. 44
Clinical Trial Overview of Aastrom Biosciences, Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
Fundacion Progreso y Salud 45
Clinical Trial Overview of Fundacion Progreso y Salud 45
Leiden University Medical Center 46
Clinical Trial Overview of Leiden University Medical Center 46
Tufts University 47
Clinical Trial Overview of Tufts University 47
Northwestern University 48
Clinical Trial Overview of Northwestern University 48
Kansai Rosai Hospital 49
Clinical Trial Overview of Kansai Rosai Hospital 49
Institute of Biomedical Research and Innovation Hospital 50
Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital 50
Sun Yat-sen University 51
Clinical Trial Overview of Sun Yat-sen University 51
CHU de Reims 52
Clinical Trial Overview of CHU de Reims 52
University of Bern 53
Clinical Trial Overview of University of Bern 53
Kyushu University 54
Clinical Trial Overview of Kyushu University 54
Five Key Clinical Profiles 55
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81

List of Tables
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Critical Limb Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Critical Limb Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AnGes MG, Inc., 2014* 35
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ViroMed Co., Ltd., 2014* 36
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by United Therapeutics Corporation, 2014* 37
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014* 38
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pluristem Therapeutics Inc., 2014* 39
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by TheraVitae Inc., 2014* 40
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by ReNeuron Group plc, 2014* 41
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Intrexon Corporation, 2014* 42
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014* 43
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aastrom Biosciences, Inc., 2014* 44
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Fundacion Progreso y Salud, 2014* 45
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2014* 46
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Tufts University, 2014* 47
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 48
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kansai Rosai Hospital, 2014* 49
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2014* 50
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 51
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CHU de Reims, 2014* 52
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bern, 2014* 53
Critical Limb Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyushu University, 2014* 54

List of Figures
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Critical Limb Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Critical Limb Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Critical Limb Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Critical Limb Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Critical Limb Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Critical Limb Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Critical Limb Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Critical Limb Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Critical Limb Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Critical Limb Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Critical Limb Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Critical Limb Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Critical Limb Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Critical Limb Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 80

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[重症虚血肢(Critical Limb Ischemia):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆